Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual ...
Bayer and Vividion Therapeutics, Inc. (Vividion) will present the latest research on their advancing oncology portfolio at the upcoming American Association for Cancer Research (AACR) 2025 Annual Meeting, taking place from April 25-30, 2025, in Chicago, …